NASH is defined as the most common form of Nonalcoholic fatty liver disease (NAFLD). The disease is characterized by a spectrum of symptoms including simple steatosis,…
Month: February 2018
Feb 22 
Snippet: M&A activities of big pharma’s will fuel CAR-T cell therapy
Gilead Sciences Inc. bought Kite Pharma (USD 11.9 Billion) while Celgene took over Juno Therapeutics (USD 9 Billion) to make the greatest speculation into this rising…
Feb 22 
The Business Cocktail : Latest Pharma deals
Ionis pharmaceuticals recently licensed-out its antisense drug to AstraZeneca in deal total worth up to USD 330 million Ionis Pharmaceuticals has recently licensed-out an antisense drug…
Feb 19 
Immune Checkpoint Activators (ICA): Dynamic Therapeutic Targets
Immune checkpoints are the regulators of immune activation. They play a key role in maintaining immune homeostasis and preventing autoimmunity. Immune checkpoint activators are small molecules…
Feb 14
Business Cocktail
Roivant expanding its horizon into metabolic diseases segment with USD 650 million diabetes pact with Poxel Roivant Sciences has recently signed a USD 650 million deal to acquire…
Feb 12 
Natural Killer Cell Therapies: An Emerging Cellular Therapy
Natural killer cells are the innate immune cells that are naturally involved in tumor immunosurveillance. These cells have direct cytotoxic activity and also secrete proinflammatory cytokines…
Feb 9 
Involvement of B cells in the pathogenesis of primary Sjögren syndrome (pSS)
Primary Sjögren syndrome (pSS) is a.prototypical autoimmune.disease. The involvement.of B cells in the pathogenesis.of pSS has long been suspected.on the basis of clinical.observations that include the.presence…
